Published online Feb 27, 2025. doi: 10.4240/wjgs.v17.i2.103378
Revised: December 19, 2024
Accepted: December 31, 2024
Published online: February 27, 2025
Processing time: 65 Days and 2 Hours
This article discusses Wang et al’s essay. Endoscopic biliary stenting, a less invasive alternative to surgery, is effective for malignant obstructive jaundice. This article summarizes the pathophysiology of biliary obstruction, the technical aspects of stenting, and the clinical outcomes. By comparison of endoscopic stenting with percutaneous biliary drainage, improvements and complications are focused on. Additionally, patient selection for stenting and future advancements in stent technology are important. Overall, endoscopic biliary stenting is a valuable palliative option for patients with malignant jaundice, especially those ineligibles for surgery.
Core Tip: Endoscopic biliary stenting is a vital palliative procedure for managing malignant obstructive jaundice, particularly in cases of distal obstruction. The procedure’s success relies on careful patient selection, accounting for factors such as tumor location, stent type, and potential complications. Recent innovations, including drug-eluting and 3-dimensional-printed stents, have enhanced clinical outcomes. A multidisciplinary approach ensures individualized treatment planning, better complication management, and improved overall patient care.
